High | P63085 | Mitogen-activated protein kinase 1 OS=Mus musculus OX=10090 GN=Mapk1 PE=1 SV=3 | 0 | 33.163 | 36 | 10 | 21 | 10 | 358 | 41.2 | 6.98 | 6 | 4 | 4 | 6 | 6 | 5 | 4 | 6 | 19367789.2 | 11890117.75 | 16112633.67 | 25087126 | 6 | 8 | 7 | 6 | Met-loss+Acetyl [N-Term] | cell communication;cell death;cell differentiation;cell proliferation;cellular homeostasis;metabolic process;regulation of biological process;response to stimulus;transport | cytoplasm;cytoskeleton;cytosol;endosome;Golgi;membrane;mitochondrion;nucleus | catalytic activity;nucleotide binding;protein binding;signal transducer activity | "Pf00069, Pf01636, Pf07714" | 26413 | ENSMUSG00000063358.15 | Mapk1 | 16 | "NCAM signaling for neurite out-growth; MAP2K and MAPK activation; Spry regulation of FGF signaling; Signal transduction by L1; FCERI mediated MAPK activation; phospho-PLA2 pathway; Regulation of HSF1-mediated heat shock response; Activated TLR4 signalling; Signaling by GPCR; Neutrophil degranulation; Gastrin-CREB signalling pathway via PKC and MAPK; MAPK1 (ERK2) activation; Recycling pathway of L1; Thrombin signalling through proteinase activated receptors (PARs); RHO GTPases Activate WASPs and WAVEs; Golgi Cisternae Pericentriolar Stack Reorganization; Interleukin-20 family signaling; RSK activation; Regulation of actin dynamics for phagocytic cup formation; Activation of the AP-1 family of transcription factors; Growth hormone receptor signaling; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling; Oxidative Stress Induced Senescence; Senescence-Associated Secretory Phenotype (SASP); Oncogene Induced Senescence; ERKs are inactivated; Negative feedback regulation of MAPK pathway" | Long-term potentiation; B cell receptor signaling pathway; Influenza A; Fc epsilon RI signaling pathway; Apoptosis; Chagas disease (American trypanosomiasis); VEGF signaling pathway; Oocyte meiosis; cGMP-PKG signaling pathway; Natural killer cell mediated cytotoxicity; Adrenergic signaling in cardiomyocytes; Acute myeloid leukemia; Tuberculosis; Fc gamma R-mediated phagocytosis; cAMP signaling pathway; Colorectal cancer; Progesterone-mediated oocyte maturation; Chemokine signaling pathway; Glutamatergic synapse; Alzheimer's disease; Leishmaniasis; Phospholipase D signaling pathway; Insulin signaling pathway; Adherens junction; HIF-1 signaling pathway; Circadian entrainment; Bladder cancer; Cholinergic synapse; Prolactin signaling pathway; Hepatitis B; Neurotrophin signaling pathway; Renal cell carcinoma; Chronic myeloid leukemia; ErbB signaling pathway; Platelet activation; Proteoglycans in cancer; Thyroid cancer; Estrogen signaling pathway; MAPK signaling pathway; Focal adhesion; Osteoclast differentiation; TGF-beta signaling pathway; Prion diseases; Prostate cancer; AGE-RAGE signaling pathway in diabetic complications; Breast cancer; Toll-like receptor signaling pathway; Alcoholism; Central carbon metabolism in cancer; Retrograde endocannabinoid signaling; TNF signaling pathway; Axon guidance; Long-term depression; GnRH signaling pathway; Serotonergic synapse; FoxO signaling pathway; Toxoplasmosis; Dorso-ventral axis formation; Hepatitis C; EGFR tyrosine kinase inhibitor resistance; T cell receptor signaling pathway; Melanogenesis; Thyroid hormone signaling pathway; Vascular smooth muscle contraction; Viral carcinogenesis; Oxytocin signaling pathway; Ras signaling pathway; Endometrial cancer; Sphingolipid signaling pathway; Pathways in cancer; Glioma; Aldosterone-regulated sodium reabsorption; Platinum drug resistance; Signaling pathways regulating pluripotency of stem cells; Salmonella infection; PI3K-Akt signaling pathway; Th1 and Th2 cell differentiation; Type II diabetes mellitus; NOD-like receptor signaling pathway; Non-small cell lung cancer; Rap1 signaling pathway; Gap junction; Endocrine resistance; mTOR signaling pathway; Melanoma; Pertussis; Pancreatic cancer; Choline metabolism in cancer; Regulation of actin cytoskeleton | 0 |